4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-025617
Pres. & Chief Executive Offic sold 720 shares at $2.41 ($1,735)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRISTOW MICHAEL R Pres. & Chief Executive Offic | 2017-04-04 | Sale | −720 | $2.41 | $1,735 | 41,155 | D |
| Open-market sales · 720 sh · avg $2.41 · $1,735 | |||||||
Loading xslF345X03/doc4.xml…